ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,016Medicare Part D Prescriptions Filled, Including Refills

Rank: 519 out of 5176

$1.03M Total Retail Price of All Prescriptions

Rank: 244 out of 5176

265 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 265 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 10,573 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

59% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$93 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
CRESTOR 600 572 1 15
METOPROLOL SUCCINATE 429 424 2 11
NEXIUM 397 388 3 16
AMLODIPINE BESYLATE 294 288 4 2
PLAVIX 288 274 5 29
METFORMIN HCL 270 257 6 7
ZOLPIDEM TARTRATE 264 253 7 17
SIMVASTATIN 210 199 8 1
BENICAR 195 195 9 100
SYNTHROID 188 188 10 33
LOVAZA 187 182 11 43
LIPITOR 178 177 12 51
HYDROCHLOROTHIAZIDE 172 169 13 10
DIOVAN HCT 171 158 14 39
CLOPIDOGREL 165 159 15 26
DIOVAN 165 165 15 19
JANUVIA 163 163 17 25
DEXILANT 161 161 18 118
AMLODIPINE BESYLATE-BENAZEPRIL 160 138 19 55
ATORVASTATIN CALCIUM 154 154 20 9
ATENOLOL-CHLORTHALIDONE 150 134 21 161
LOSARTAN POTASSIUM 142 138 22 14
BENICAR HCT 135 130 23 110
ACTOS 131 131 24 85
CELEBREX 127 127 25 80
LIDODERM 114 114 26 59
ESCITALOPRAM OXALATE 101 101 27 89
FUROSEMIDE 99 99 28 8
OMEPRAZOLE 91 83 29 3
METFORMIN HCL ER 90 90 30 57
POTASSIUM CHLORIDE 89 89 31 34
LUNESTA 86 86 32 242
TAMSULOSIN HCL 82 82 33 20
LACTULOSE 81 79 34 87
QUINAPRIL HCL 79 76 35 82
BYSTOLIC 77 70 36 96
DIGOXIN 76 76 37 56
TRAMADOL HCL-ACETAMINOPHEN 76 68 37 116
NAMENDA 76 76 37 47
ALLOPURINOL 76 65 37 41
ISOSORBIDE MONONITRATE ER 76 72 37 44
ALENDRONATE SODIUM 75 75 42 18
WARFARIN SODIUM 75 75 42 13
PRADAXA 70 70 44 192
NAPROXEN 67 63 45 95
LEXAPRO 67 67 45 193
LEVOTHYROXINE SODIUM 65 64 47 4
DICYCLOMINE HCL 63 61 48 224
MULTAQ 63 63 48 414
AZITHROMYCIN 62 58 50 42
CREON 62 55 50 111
LOSARTAN-HYDROCHLOROTHIAZIDE 61 57 52 35
MECLIZINE HCL 61 57 52 81
AVODART 60 60 54 107
MICARDIS HCT 59 59 55 180
CYMBALTA 58 46 56 90
ATENOLOL 58 53 56 12
METOPROLOL TARTRATE 58 50 56 6
CLOBETASOL PROPIONATE 54 51 59 130
MICARDIS 52 42 60 154
CARVEDILOL 52 49 60 24
EXELON 51 51 62 162
VOLTAREN 50 48 63 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.